Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

Minoxidil solution increases hair growth; Shampoo B best for dandruff; infliximab helps pemphigus vulgaris.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Promising cancer treatments were found, but the manufacturer closed.

TREM2 macrophages and unsaturated lipids contribute to acne inflammation.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Dupilumab may help treat alopecia areata, but more research is needed.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Bexarotene gel shows promise as a new treatment for alopecia areata.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Dupilumab for skin problems might reactivate hair loss in some patients.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

The new filler effectively and safely improves tear trough deformity long-term.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

Interest in JAK inhibitors for hair loss increased significantly after media coverage and FDA approval.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.